Dr Michael Schneider appointed Norma Group's CEO

The Supervisory Board of NORMA Group, a global market leader in engineered joining technology, has appointed Dr. Michael Schneider Chairman of the Management Board on a permanent basis today. Dr. Schneider had already taken on the duties of interim CEO in addition to his responsibilities as CFO on August 1, 2019. His predecessor Bernd Kleinhens stepped down from the Management Board by mutual agreement on July 31, 2019.

“We are pleased that Dr. Michael Schneider has accepted the appointment as Chief Executive Officer. We are convinced that he will be successful in further developing NORMA Group,” said Lars Magnus Berg, Chairman of the Supervisory Board of NORMA Group SE. “With this appointment, we are expressing our confidence in Dr. Michael Schneider and look forward to working with him in the future.”

Dr. Michael Schneider has been a member of the Management Board and Chief Financial Officer (CFO) of NORMA Group since July 1, 2015. Before that, he held management positions with various companies in the automobile and chemical industry as well as in medical technology in Germany and abroad.

“I am convinced that Dr. Michael Schneider will strengthen and further extend NORMA Group’s strong position as an international market leader for engineered and standardized joining technology and fluid handling systems even through difficult times,” said Lars Magnus Berg, Chairman of the Supervisory Board of NORMA Group SE.

Besides serving as Chairman of the Management Board, Dr. Michael Schneider will retain his role as Chief Financial Officer until further notice. The Management Board of NORMA Group SE currently consists of two members. Dr. Friedrich Klein, Chief Operating Officer (COO), is the other member of the Management Board. The Supervisory Board will most likely decide on other positions on the Management Board in the months to come.